Bharvin Kumar Patel
10Patents
4h-index
20Co-inventors
60Inventor score
Filing activity: Feb 23, 2000 → May 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7541344B2 | Modulation of survivin expression | Chemistry; Metallurgy | 112 | Expired |
| US10688104B2 | Combination therapy with Notch and PD-1 or PD-L1 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9000023B2 | Disubstituted phthalazine hedgehog pathway antagonists | Human Necessities | 5 | Active |
| US6368828B1 | Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c | Chemistry; Metallurgy | 4 | Expired |
| US11298362B2 | Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer | Human Necessities | 3 | Active |
| US8273742B2 | Disubstituted phthalazine hedgehog pathway antagonists | Human Necessities | 2 | Active |
| US11564929B2 | Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US11826317B2 | Combination therapy with notch and PD-1 or PD-L1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10787460B2 | (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7 | Chemistry; Metallurgy | 0 | Active |
| US10450317B2 | Notch pathway signaling inhibitor compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.